Ask AI

Global Insights, Local Impact: Practical Pathways for Integrating Biomarkers in Alzheimer’s Care

Blood-based biomarkers offer a transformative tool for early detection and diagnosis of Alzheimer’s disease, as a noninvasive and cost-effective alternative to PET and CSF testing. International AD experts offer insight on how BBM assessment can be integrated into clinical practice, including consideration of regional differences in healthcare pathways, access structures, and cultural expectations. Activities include global panel discussions and region-specific workshops, with multilingual translations available. 

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Lilly.

Lilly